Identified more than 20 years after the cystic fibrosis gene behind was a pill that the problem would be for some people to solve is closer to reality.
Experimental medicine twice a day, listen to the name of VX-770 code. Now there are promising results from a study of 161 people with a specific genetic mutation that affects about four percent of patients with cystic fibrosis.
Lung function by 10 percentage points on average among those in the drug group were compared to patients given placebo. The improvement was still present six months almost a year after the start of the study.
No comments:
Post a Comment